Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 331.00
Bid: 328.00
Ask: 333.00
Change: 10.50 (3.28%)
Spread: 5.00 (1.524%)
Open: 316.50
High: 333.00
Low: 315.00
Prev. Close: 320.50
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Investec prefers 888 over Entain

Tue, 28th Sep 2021 09:40

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

----------

FTSE 100

----------

CITIGROUP RAISES BRITISH LAND TO 'NEUTRAL' ('SELL') - TARGET 526 (285) PENCE

----------

CITIGROUP RAISES LAND SECURITIES TO 'NEUTRAL' ('SELL') - TARGET 755 (506) PENCE

----------

UBS RAISES SPIRAX-SARCO PRICE TARGET TO 16,000 (12,500) PENCE - 'NEUTRAL'

----------

UBS RAISES DS SMITH PRICE TARGET TO 422 (414) PENCE - 'NEUTRAL'

----------

DEUTSCHE BANK RAISES PRUDENTIAL PRICE TARGET TO 1,680 (1,650) PENCE - 'BUY'

----------

GOLDMAN SACHS CUTS SAGE GROUP TO 'SELL' ('NEUTRAL') - TARGET 700 (660) PENCE

----------

INVESTEC INITIATES ENTAIN WITH 'HOLD' - TARGET 2,400 PENCE

----------

JPMORGAN RAISES UNITED UTILITIES TARGET TO 1,060 (1,050) PENCE - 'OVERWEIGHT'

----------

HSBC RAISES FLUTTER TO 'BUY' (HOLD) - PRICE TARGET 17,400 (14,000) PENCE

----------

UBS CUTS MONDI PRICE TARGET TO 2,100 (2,200) PENCE - 'BUY'

----------

UBS CUTS BRITISH AMERICAN TOBACCO PRICE TARGET TO 3,500 (3,600) PENCE - 'BUY'

----------

JPMORGAN RAISES ROLLS-ROYCE PRICE TARGET TO 150 (130) PENCE - 'NEUTRAL'

----------

FTSE 250

----------

RBC RAISES ELECTROCOMPONENTS TO 'OUTPERFORM' ('SECTOR PERFORM') - TARGET 1,350 (1,070) PENCE

INVESTEC RESUMES 888 HOLDINGS WITH 'BUY' - TARGET 660 PENCE

JEFFERIES RAISES OXFORD BIOMEDICA PRICE TARGET TO 1,450 (1,180) PENCE - 'HOLD'

----------

OTHER MAIN MARKET AND AIM

----------

UBS RAISES RYANAIR PRICE TARGET TO 17.5 (16.8) EUR - 'NEUTRAL'

----------

PEEL HUNT RAISES NEXT FIFTEEN TO 'ADD' ('HOLD') - TARGET 1,220 (1,130) PENCE

----------

PEEL HUNT RAISES GAMMA COMMUNICATIONS TO 'BUY' ('HOLD') - TARGET 2,225 PENCE

----------

BERENBERG RAISES SUPERDRY PRICE TARGET TO 280 (235) PENCE - 'HOLD'

----------

PEEL HUNT INITIATES CLIPPER LOGISTICS WITH 'HOLD' - TARGET 865 PENCE

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
29 Apr 2016 12:54

DIRECTOR DEALINGS: Oxford Biomedica Executive Director Buys Shares

Read more
28 Apr 2016 08:37

Oxford Biomedica Loss Widens As Research Spending And Staff Grow

Read more
25 Apr 2016 08:29

DIRECTOR DEALINGS: Oxford BioMedica Chairman Ups Interest

Read more
21 Apr 2016 15:05

Earnings, Trading Statements Calendar - Week Ahead

Read more
4 Apr 2016 06:39

IXICO Enters Parkinson's Consortium And Secures Oxford Biomedica Deal

Read more
24 Mar 2016 11:14

DIRECTOR DEALINGS: Oxford Biomedica Chairman Ups Interest

Read more
7 Mar 2016 09:25

Oxford BioMedica Expands Collaboration, Inks Deal With Immune Design

Read more
25 Feb 2016 18:03

DIRECTOR DEALINGS: Oxford BioMedica Chairman Buys First Shares

Read more
23 Feb 2016 12:23

Oxford Biomedica to raise £8.1m in placing

(ShareCast News) - Biopharmaceutical company Oxford Biomedica plans to raise £8.1m in a placing of 128.4m shares at 6.3p with new and existing investors. The placing, which is priced at a 10% discount to the 7p closing price on 22 February, is to provide adequate working capital for the group to con

Read more
23 Feb 2016 08:26

Oxford BioMedica To Raise GBP8.1 Million In Discounted Placing (ALLISS)

Read more
29 Jan 2016 08:09

Oxford Biomedica Starts New Programme Under Novartis Deal

Read more
13 Jan 2016 08:43

Oxford Biomedica Gets UK Bulk Drug Manufacturing Approvals

Read more
15 Dec 2015 08:57

Oxford Biomedica Names Lorenzo Tallarigo As New Chairman

Read more
4 Nov 2015 10:42

Oxford BioMedica Making Progress On Strategy And Clinical Trials

Read more
28 Oct 2015 08:49

Oxford Biomedica Says Glaxo Exercises LentiVector Platform Option

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.